These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36744372)

  • 21. Formulation Development, In Vitro and In Vivo Evaluation of Topical Hydrogel Formulation of Econazole Nitrate-Loaded β-Cyclodextrin Nanosponges.
    Srivastava S; Mahor A; Singh G; Bansal K; Singh PP; Gupta R; Dutt R; Alanazi AM; Khan AA; Kesharwani P
    J Pharm Sci; 2021 Nov; 110(11):3702-3714. PubMed ID: 34293406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo evaluation of cyclodextrin-based nanosponges for enhancing oral bioavailability of atorvastatin calcium.
    Zidan MF; Ibrahim HM; Afouna MI; Ibrahim EA
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1243-1253. PubMed ID: 29452493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclodextrin based nanosponges for pharmaceutical use: a review.
    Tejashri G; Amrita B; Darshana J
    Acta Pharm; 2013 Sep; 63(3):335-58. PubMed ID: 24152895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization.
    Sherje AP; Surve A; Shende P
    J Mater Sci Mater Med; 2019 Jun; 30(6):74. PubMed ID: 31197491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melt sonocrystallized piroxicam for oral delivery: particle characterization, solid state analysis, and pharmacokinetics.
    Gupta PS; Sharma V; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):17-32. PubMed ID: 23102052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclodextrin-based nanosponges: effective nanocarrier for tamoxifen delivery.
    Torne S; Darandale S; Vavia P; Trotta F; Cavalli R
    Pharm Dev Technol; 2013; 18(3):619-25. PubMed ID: 22235935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incorporation of exemestane into ternary nanosponge system for enhanced anti-tumor potential in breast cancer.
    Mane PT; Wakure BS; Wakte PS
    Pharm Dev Technol; 2023 Dec; 28(10):1000-1015. PubMed ID: 37961995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclodextrin based nanosponge of norfloxacin: Intestinal permeation enhancement and improved antibacterial activity.
    Mendes C; Meirelles GC; Barp CG; Assreuy J; Silva MAS; Ponchel G
    Carbohydr Polym; 2018 Sep; 195():586-592. PubMed ID: 29805015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclodextrin Based Nanosponges: A Multidimensional Drug Delivery System and its Biomedical Applications.
    Mane PT; Wakure BS; Wakte PS
    Curr Drug Deliv; 2021; 18(10):1467-1493. PubMed ID: 33902410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cyclodextrin nanosponges for delivery of calcium in hyperphosphatemia.
    Shende P; Deshmukh K; Trotta F; Caldera F
    Int J Pharm; 2013 Nov; 456(1):95-100. PubMed ID: 23954237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanosponge hydrogel of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalis.
    El-Sayed SE; Abdelaziz NA; El-Housseiny GS; Aboshanab KM
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):100. PubMed ID: 38217256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hydroxypropyl-beta-cyclodextrin complexation on piroxicam release from buccoadhesive tablets.
    Jug M; Bećirević-Laćan M
    Eur J Pharm Sci; 2004 Feb; 21(2-3):251-60. PubMed ID: 14757497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation
    Zainuddin R; Zaheer Z; Sangshetti JN; Momin M
    Drug Dev Ind Pharm; 2017 Dec; 43(12):2076-2084. PubMed ID: 28845699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimisation of a Greener-Approach for the Synthesis of Cyclodextrin-Based Nanosponges for the Solubility Enhancement of Domperidone, a BCS Class II Drug.
    Vij M; Dand N; Kumar L; Wadhwa P; Wani SUD; Mahdi WA; Alshehri S; Alam P; Shakeel F
    Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboxylate cross-linked cyclodextrin: A nanoporous scaffold for enhancement of rosuvastatin oral bioavailability.
    Gabr MM; Mortada SM; Sallam MA
    Eur J Pharm Sci; 2018 Jan; 111():1-12. PubMed ID: 28931488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound.
    Van Hees T; Piel G; Evrard B; Otte X; Thunus L; Delattre L
    Pharm Res; 1999 Dec; 16(12):1864-70. PubMed ID: 10644075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of cyclodextrin complexation on piroxicam gel formulations.
    Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
    Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding Surface Interaction and Inclusion Complexes between Piroxicam and Native or Crosslinked β-Cyclodextrins: The Role of Drug Concentration.
    Raffaini G; Ganazzoli F
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32575617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Formulation Optimization and Biopharmaceutical Evaluation of Imatinib Mesylate Loaded β-cyclodextrin Nanosponges.
    Kamble M; Zaheer Z; Mokale S; Zainuddin R
    Pharm Nanotechnol; 2019; 7(5):343-361. PubMed ID: 31549599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicomponent complexes of piroxicam with cyclodextrins and hydroxypropyl methylcellulose.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2004; 30(10):1051-60. PubMed ID: 15595571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.